Cepheid (CPHD -22%) shares plunge after Q2 earnings fell 38%, hurt by higher costs that masked...

|By:, SA News Editor

Cepheid (CPHD -22%) shares plunge after Q2 earnings fell 38%, hurt by higher costs that masked strong revenue growth, and the company lowered full-year earnings targets. But Baird believes the weakness could be a buying opportunity, citing CPHD's test menu expansion, highly differentiated positioning and strong base growth; the firm rates shares at Outperform.